EPISODE · Dec 3, 2020 · 22 MIN
Insights from Biotech Pioneer and Investor Ron Shigeta
from From Lab to Launch by Qualio · host Ron Shigeta
Ron Shigeta is a serial entrepreneur & startup biotech pioneer. He’s also been a serial founder having run startups in AI drug tox detection & synthetic biology. Ron holds a PhD in Chemistry from Princeton University, where he spent his academic research career focusing on secondary metabolic biosynthesis, diabetes, genomics, genetics, structural biology and systems biology. As an entrepreneur, investor, scientist, and mentor Ron shares some great insights to anyone who wants to contribute to life sciences. Some takeaways:Starting a biotech company today is much easier and cheaper than at any other timeAdvice to founders to gain relevancy and trust from investors and get fundingBiotech investments now are where software was 2+ decades agoLinks:https://www.linkedin.com/in/startupminute/https://www.alix.vc/ron-shigetaThe Bio Revolution by McKinsey Global Institute See more information about From Lab to Launch by QualioMusic by keldezQualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez
Embed this episode
What this episode covers
Ron Shigeta is a serial entrepreneur & startup biotech pioneer. He’s also been a serial founder having run startups in AI drug tox detection & synthetic biology. Ron holds a PhD in Chemistry from Princeton University, where he spent his academic research career focusing on secondary metabolic biosynthesis, diabetes, genomics, genetics, structural biology and systems biology. As an entrepreneur, investor, scientist, and mentor Ron shares some great insights to anyone who wants t...
NOW PLAYING
Insights from Biotech Pioneer and Investor Ron Shigeta
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.